메뉴 건너뛰기




Volumn 4, Issue 10, 2012, Pages 1211-1213

Deployment of in silico and in vitro safety assays in early-stage drug discovery

Author keywords

cell based; in silico; in vitro; physiochemical; safety assessment; toxicityty

Indexed keywords

SULFONAMIDE;

EID: 84863899238     PISSN: 17568919     EISSN: 17568927     Source Type: Journal    
DOI: 10.4155/fmc.12.71     Document Type: Review
Times cited : (5)

References (20)
  • 2
    • 4344645978 scopus 로고    scopus 로고
    • Can the pharmaceutical industry reduce attrition rates
    • Kola I, Landis J. Can the pharmaceutical industry reduce attrition rates? Nat. Rev. Drug Discov. 3(8), 711-715 (2004).
    • (2004) Nat. Rev. Drug Discov. , vol.3 , Issue.8 , pp. 711-715
    • Kola, I.1    Landis, J.2
  • 3
    • 69249126232 scopus 로고    scopus 로고
    • TOX 21: New dimensions of toxicity testing
    • Charles W, Schmidt MS. TOX 21: New dimensions of toxicity testing. Environ. Health Perspect. 117(8), A348-A353 (2009).
    • (2009) Environ. Health Perspect. , vol.117 , Issue.8
    • Charles, W.1    Schmidt, M.S.2
  • 4
    • 84863956553 scopus 로고
    • Toxicity of sulphonamide drugs to cells in vitro
    • Jacoby F, Medawar PB, Willmer EN. Toxicity of sulphonamide drugs to cells in vitro. Br. Med. J. 2(4204), 149-153 (1941).
    • (1941) Br. Med. J. , vol.2 , Issue.4204 , pp. 149-153
    • Jacoby, F.1    Medawar, P.B.2    Willmer, E.N.3
  • 5
    • 10044257811 scopus 로고    scopus 로고
    • A comparison of hepatocyte cytotoxic mechanisms for chromate and arsenite
    • Pourahmad J, Rabiei M, Jokar F, O'brien PJ. A comparison of hepatocyte cytotoxic mechanisms for chromate and arsenite. Toxicology 206(3), 449-460 (2005).
    • (2005) Toxicology , vol.206 , Issue.3 , pp. 449-460
    • Pourahmad, J.1    Rabiei, M.2    Jokar, F.3    O'brien, P.J.4
  • 6
    • 33845340506 scopus 로고    scopus 로고
    • Future of toxicology-Mechanisms of toxicity and drug safety: Where do we go from here
    • Stevens JL. Future of toxicology-Mechanisms of toxicity and drug safety: Where do we go from here? Chem. Res. Toxicol. 19(11), 1393-1401 (2006).
    • (2006) Chem. Res. Toxicol. , vol.19 , Issue.11 , pp. 1393-1401
    • Stevens, J.L.1
  • 7
    • 29544450979 scopus 로고    scopus 로고
    • Mode of action in relevance of rodent liver tumors to human cancer risk
    • Holsapple MP, Pitot HC, Cohen SM et al. Mode of action in relevance of rodent liver tumors to human cancer risk. Toxicol. Sci. 89(1), 51-56 (2006).
    • (2006) Toxicol. Sci. , vol.89 , Issue.1 , pp. 51-56
    • Holsapple, M.P.1    Pitot, H.C.2    Cohen, S.M.3
  • 8
    • 0035289779 scopus 로고    scopus 로고
    • Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
    • Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 46(1-3), 3-26 (2001).
    • (2001) Adv. Drug Deliv. Rev. , vol.46 , Issue.1-3 , pp. 3-26
    • Lipinski, C.A.1    Lombardo, F.2    Dominy, B.W.3    Feeney, P.J.4
  • 9
    • 39749181550 scopus 로고    scopus 로고
    • Generation of a set of simple, interpretable ADMET rules of thumb
    • Gleeson MP. Generation of a set of simple, interpretable ADMET rules of thumb. J. Med. Chem. 51(4), 817-834 (2008).
    • (2008) J. Med. Chem. , vol.51 , Issue.4 , pp. 817-834
    • Gleeson, M.P.1
  • 10
    • 49849094738 scopus 로고    scopus 로고
    • Physiochemical drug properties associated with in vivo toxicological outcomes
    • Hughes JD, Blagg J, Price DA et al. Physiochemical drug properties associated with in vivo toxicological outcomes. Biorg. Med. Chem. Lett. 18(17), 4872-4875 (2008).
    • (2008) Biorg. Med. Chem. Lett. , vol.18 , Issue.17 , pp. 4872-4875
    • Hughes, J.D.1    Blagg, J.2    Price, D.A.3
  • 11
    • 35748934487 scopus 로고    scopus 로고
    • The influence of drug-like concepts on decision-Making in medicinal chemistry
    • Leeson PD, Springthorpe B. The influence of drug-like concepts on decision-Making in medicinal chemistry. Nat. Rev. Drug Discov. 6(11), 881-890 (2007).
    • (2007) Nat. Rev. Drug Discov. , vol.6 , Issue.11 , pp. 881-890
    • Leeson, P.D.1    Springthorpe, B.2
  • 12
    • 79955591890 scopus 로고    scopus 로고
    • Yin and Yang in medicinal chemistry: What does drug-likeness mean
    • Macarrón R, Luengo JI. Yin and Yang in medicinal chemistry: What does drug-likeness mean? Future Med. Chem. 3(5), 505-507 (2011).
    • (2011) Future Med. Chem. , vol.3 , Issue.5 , pp. 505-507
    • Macarrón, R.1    Luengo, J.I.2
  • 13
    • 84857963032 scopus 로고    scopus 로고
    • Evaluation of drugs with specific organ toxicities in organ-Specific cell lines
    • Lin Z, Will Y. Evaluation of drugs with specific organ toxicities in organ-Specific cell lines. Toxicol. Sci. 126(1), 114-127 (2012).
    • (2012) Toxicol. Sci. , vol.126 , Issue.1 , pp. 114-127
    • Lin, Z.1    Will, Y.2
  • 14
    • 77955663637 scopus 로고    scopus 로고
    • Using an in vitro cytotoxicity assay to aid in compound selection for in vivo safety studies
    • Greene N, Aleo MD, Louise-May S, Price DA, Will Y. Using an in vitro cytotoxicity assay to aid in compound selection for in vivo safety studies. Bioorg. Med. Chem. Lett. 20(17), 5308-5312 (2010).
    • (2010) Bioorg. Med. Chem. Lett. , vol.20 , Issue.17 , pp. 5308-5312
    • Greene, N.1    Aleo, M.D.2    Louise-May, S.3    Price, D.A.4    Will, Y.5
  • 15
    • 80052467190 scopus 로고    scopus 로고
    • Predicting in vivo safety characteristics using physiochemical properties and in vitro assays
    • Greene N, Song M. Predicting in vivo safety characteristics using physiochemical properties and in vitro assays. Future Med. Chem. 3(12), 1503-1511 (2011).
    • (2011) Future Med. Chem. , vol.3 , Issue.12 , pp. 1503-1511
    • Greene, N.1    Song, M.2
  • 16
    • 78649630186 scopus 로고    scopus 로고
    • The future of toxicity testing: A focus on in vitro methods using a quantitative high-Throughput screening platfor.m
    • Shukla SJ, Huang R, Austin CP, Xia M. The future of toxicity testing: A focus on in vitro methods using a quantitative high-Throughput screening platform. Drug Discov. Today 15(23-24), 997-1007 (2010).
    • (2010) Drug Discov Today , vol.15 , Issue.23-24 , pp. 997-1007
    • Shukla, S.J.1    Huang, R.2    Austin, C.P.3    Xia, M.4
  • 17
    • 67649185786 scopus 로고    scopus 로고
    • Toxicity testing in the 21st century: A view from the pharmaceutical industry
    • MacDonald JS, Robertson RT. Toxicity testing in the 21st century: A view from the pharmaceutical industry. Toxicol. Sci. 110(1), 40-46 (2009).
    • (2009) Toxicol. Sci. , vol.110 , Issue.1 , pp. 40-46
    • MacDonald, J.S.1    Robertson, R.T.2
  • 18
    • 79959431802 scopus 로고    scopus 로고
    • The electrophysiological effects of cardiac glycosides in human iPSC-Derived cardiomyocytes and in guinea pig isolated hearts
    • Guo L, Qian JY, Abrams R, et al. The electrophysiological effects of cardiac glycosides in human iPSC-Derived cardiomyocytes and in guinea pig isolated hearts. Cell. Physiol. Biochem. 27(5), 453-462 (2011).
    • (2011) Cell. Physiol. Biochem. , vol.27 , Issue.5 , pp. 453-462
    • Guo, L.1    Qian, J.Y.2    Abrams, R.3
  • 20
    • 38049011979 scopus 로고    scopus 로고
    • Microscale culture of human liver cells for drug development
    • Khetani SR, Bhatia SN. Microscale culture of human liver cells for drug development. Nat. Biotechnol. 26(1), 120-126 (2008)
    • (2008) Nat. Biotechnol. , vol.26 , Issue.1 , pp. 120-126
    • Khetani, S.R.1    Bhatia, S.N.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.